Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Haematologica ; 90 Suppl: ECR27, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16266918

RESUMEN

Post-transplantation lymphoproliferative disorder is an infrequent complication after hematopoietic stem cell transplantation. It is hypothesized that lack of T-cell surveillance following transplantation permits reactivation of latent EBV leading to polyclonal B-cell expansion and finally outgrowth of a predominant clone. Most cases are of donor origin. Here, we describe an 8-year old boy with early onset post-transplantation lymphoproliferative disorder following matched-unrelated stem cell transplantation for high-risk T-cell leukemia whose disease was unusual for two reasons. First, his B-cell clone was of host origin and, in contrast to the few PTLD of host origin described so far, not associated with autologous reconstitution. Secondly, using clonal analysis, we could retrospectively show that the B-cell clone emerged during consolidation chemotherapy for T-cell leukemia, 3 months before stem cell transplantation.


Asunto(s)
Linfocitos B/patología , Células Clonales/patología , Infecciones por Virus de Epstein-Barr/complicaciones , Leucemia-Linfoma de Células T del Adulto/cirugía , Trastornos Linfoproliferativos/etiología , Complicaciones Posoperatorias/etiología , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Suero Antilinfocítico/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Asparaginasa/administración & dosificación , Asparaginasa/efectos adversos , Niño , Terapia Combinada , Ciclofosfamida/administración & dosificación , Ciclosporina/efectos adversos , Ciclosporina/uso terapéutico , Citarabina/administración & dosificación , Daunorrubicina/administración & dosificación , Daunorrubicina/efectos adversos , Dexametasona/administración & dosificación , Etopósido/administración & dosificación , Etopósido/farmacología , Resultado Fatal , Glucocorticoides/administración & dosificación , Glucocorticoides/efectos adversos , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Leucemia-Linfoma de Células T del Adulto/patología , Transfusión de Linfocitos , Trastornos Linfoproliferativos/tratamiento farmacológico , Trastornos Linfoproliferativos/patología , Trastornos Linfoproliferativos/virología , Masculino , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/patología , Complicaciones Posoperatorias/virología , Prednisolona/efectos adversos , Prednisolona/uso terapéutico , Rituximab , Factores de Tiempo , Quimera por Trasplante , Acondicionamiento Pretrasplante , Vincristina/administración & dosificación , Vincristina/efectos adversos , Activación Viral/efectos de los fármacos , Irradiación Corporal Total
2.
Eur J Pediatr ; 163(7): 374-7, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15138809

RESUMEN

UNLABELLED: Neonates with Down syndrome can present with a haematological disorder called transient abnormal myelopoiesis (TAM). While TAM is usually a self-limiting disease, patients with severe complications such as hydrops fetalis, cardiorespiratory failure and liver fibrosis have been described. Here, we present five consecutive neonates with trisomy 21 and TAM, four of whom were critically ill and were therefore treated with cytosine-arabinoside. All five patients survived. CONCLUSION: severely affected neonates with Down syndrome and transient abnormal myelopoiesis might benefit from early cytostatic treatment with cytosine-arabinoside.


Asunto(s)
Síndrome de Down/complicaciones , Enfermedades Hematológicas/etiología , Mielopoyesis , Recuento de Células Sanguíneas , Células Sanguíneas/efectos de los fármacos , Células Sanguíneas/metabolismo , Citarabina/uso terapéutico , Femenino , Humanos , Hidropesía Fetal/etiología , Inmunosupresores/uso terapéutico , Recién Nacido , Cirrosis Hepática/etiología , Masculino , Insuficiencia Respiratoria/etiología , Resultado del Tratamiento
3.
In Silico Biol ; 2(3): 393-406, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12542422

RESUMEN

Pattern formation in multicellular spheroids is addressed with a hybrid lattice-gas cellular automaton model. Multicellular spheroids serve as experimental model system for the study of avascular tumor growth. Typically, multicellular spheroids consist of a necrotic core surrounded by rings of quiescent and proliferating tumor cells, respectively. Furthermore, after an initial exponential growth phase further spheroid growth is significantly slowed down even if further nutrient is supplied. The cellular automaton model explicitly takes into account mitosis, apoptosis and necrosis as well as nutrient consumption and a diffusible signal that is emitted by cells becoming necrotic. All cells follow identical interaction rules. The necrotic signal induces a chemotactic migration of tumor cells towards maximal signal concentrations. Starting from a small number of tumor cells automaton simulations exhibit the self-organized formation of a layered structure consisting of a necrotic core, a ring of quiescent tumor cells and a thin outer ring of proliferating tumor cells.


Asunto(s)
Neoplasias/patología , División Celular , Quimiotaxis , Modelos Biológicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...